Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02198482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04609826. IPD Sharing: YES. Countries: 4. Publications: 0.
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03410407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02323022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00744081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01570465. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07306832. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03388749. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
ClinicalTrials.gov study NCT07384715. IPD Sharing: NO. Countries: 0. Publications: 0.
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01329471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidemiology of Infection in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06797648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT06197672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
ClinicalTrials.gov study NCT00655395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01027923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients
ClinicalTrials.gov study NCT05188326. IPD Sharing: NO. Countries: 1. Publications: 0.
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05445154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
ClinicalTrials.gov study NCT03333005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07223814. IPD Sharing: YES. Countries: 0. Publications: 0.
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
ClinicalTrials.gov study NCT03823352. IPD Sharing: NO. Countries: 1. Publications: 0.
Single-Center Phase 1 Study With Escalating Doses of Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia (AML). TOCIVENA
ClinicalTrials.gov study NCT07392814. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.